Page last updated: 2024-08-25

topsentin and Carcinoma, Pancreatic Ductal

topsentin has been researched along with Carcinoma, Pancreatic Ductal in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Avan, A; Carbone, D; Cascioferro, S; Diana, P; Giovannetti, E; Parrino, B; Pecoraro, C; Peters, GJ; Puerta, A	1

Other Studies

1 other study(ies) available for topsentin and Carcinoma, Pancreatic Ductal

Article	Year
A New Oxadiazole-Based Topsentin Derivative Modulates Cyclin-Dependent Kinase 1 Expression and Exerts Cytotoxic Effects on Pancreatic Cancer Cells. Molecules (Basel, Switzerland), 2021, Dec-21, Volume: 27, Issue:1 Topics: Antineoplastic Agents; Apoptosis; Carcinoma, Pancreatic Ductal; Catalytic Domain; CDC2 Protein Kinase; Cell Line, Tumor; Cell Proliferation; Drug Screening Assays, Antitumor; Humans; Imidazoles; Indoles; Molecular Docking Simulation; Oxadiazoles; Pancreatic Neoplasms; Protein Binding; Protein Kinase Inhibitors; Signal Transduction; Structure-Activity Relationship	2021

Article

Year

A New Oxadiazole-Based Topsentin Derivative Modulates Cyclin-Dependent Kinase 1 Expression and Exerts Cytotoxic Effects on Pancreatic Cancer Cells.

Molecules (Basel, Switzerland), 2021, Dec-21, Volume: 27, Issue:1

Topics: Antineoplastic Agents; Apoptosis; Carcinoma, Pancreatic Ductal; Catalytic Domain; CDC2 Protein Kinase; Cell Line, Tumor; Cell Proliferation; Drug Screening Assays, Antitumor; Humans; Imidazoles; Indoles; Molecular Docking Simulation; Oxadiazoles; Pancreatic Neoplasms; Protein Binding; Protein Kinase Inhibitors; Signal Transduction; Structure-Activity Relationship

2021